Justin Yan Chen
Directeur des opérations chez Tongjitang Chinese Medicines Co.
Profil
Justin Yan Chen is currently the Chief Operating Officer & Executive Director at Tongjitang Chinese Medicines Co. He previously worked as the Head-Project Investment at Citychamp Watch & Jewellery Group Ltd.
Mr. Chen holds an MBA from the University of Lancaster and an undergraduate degree from the University of International Business & Economics.
Postes actifs de Justin Yan Chen
| Sociétés | Poste | Début |
|---|---|---|
Tongjitang Chinese Medicines Co.
 Tongjitang Chinese Medicines Co. Pharmaceuticals: MajorHealth Technology Tongjitang Chinese Medicines Co. is a pharmaceutical company engaged in the development, manufacture, marketing, and sale of modernized Chinese medicine. It offers products that are used for the treatment of osteoporosis, insomnia and improvement of sleep quality, itchiness, vertigo, side-effects of radiotherapy and chemotherapy, rheumatoid arthritis, chronic obstructive pulmonary disease (COPD), and osteoarthritis or cervical spondylosis. The company was founded in December 1995 and is headquartered in Shenzhen, China. | Directeur des opérations | 07/12/2009 |
Anciens postes connus de Justin Yan Chen
| Sociétés | Poste | Fin |
|---|---|---|
| CITYCHAMP WATCH & JEWELLERY GROUP LIMITED | Corporate Officer/Principal | - |
Formation de Justin Yan Chen
| University of Lancaster | Masters Business Admin |
| University of International Business & Economics | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CITYCHAMP WATCH & JEWELLERY GROUP LIMITED | Producer Manufacturing |
| Entreprise privées | 1 |
|---|---|
Tongjitang Chinese Medicines Co.
Tongjitang Chinese Medicines Co. Pharmaceuticals: MajorHealth Technology Tongjitang Chinese Medicines Co. is a pharmaceutical company engaged in the development, manufacture, marketing, and sale of modernized Chinese medicine. It offers products that are used for the treatment of osteoporosis, insomnia and improvement of sleep quality, itchiness, vertigo, side-effects of radiotherapy and chemotherapy, rheumatoid arthritis, chronic obstructive pulmonary disease (COPD), and osteoarthritis or cervical spondylosis. The company was founded in December 1995 and is headquartered in Shenzhen, China. | Health Technology |